Connect with us

Hi, what are you looking for?

TheSmartCitizenReport.com

BREAKING NEWS

Senate committee to vote on Dr. Oz’s nomination to run the Centers for Medicare and Medicaid Services

The Senate Committee on Finance is set to vote later Tuesday afternoon on whether to advance President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, Dr. Mehmet Oz, to a full Senate confirmation vote. 

The vote follows two hearings by the committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.   

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. 

Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.

Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate. 

Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation. 

On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.

This post appeared first on FOX NEWS

Enter Your Information Below To Receive Latest News, And Articles.







    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    BREAKING NEWS

    Israeli authorities said four Israeli Defense Forces (IDF) soldiers were killed and nearly 60 people were wounded in a drone strike on a military...

    BREAKING NEWS

    Rescue services in Israel said over 60 people were wounded, some of them critically, in a drone strike in Binyamina, Israel, which the Lebanon-based...

    BREAKING NEWS

    Former President Trump ripped President Biden for going weeks without speaking with Israeli Prime Minister Benjamin Netanyahu as war continues raging in the nation,...

    BREAKING NEWS

    JOHANNESBURG – In what is described by some as electioneering and a last-minute attempt to leave a legacy, some observers say President Biden and...

    BREAKING NEWS

    Vice President Kamala Harris and former President Donald Trump are locked in an extremely tight contest for the White House, with voters virtually split...

    BREAKING NEWS

    Voters in storm-ravaged parts of the Southeast could face new hurdles at the ballot box this year following the destruction wrought by Hurricanes Helene...

    BREAKING NEWS

    Former National Institutes of Health employee Margaret Moore, accused by Republicans of helping others shield emails from the public, invoked her Fifth Amendment right...

    BREAKING NEWS

    A ‘painful’Israeli response weighs over the heads of the Iranian regime after their ballistic missile attacks on Tel Aviv on Tuesday.  President Joe Biden has...

    Disclaimer: TheSmartCitizenReport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.

    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.